ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Potential roles of microRNAs in chronic rhinosinusitis: from mechanistic insights to clinical studies.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundChronic rhinosinusitis (CRS) is a complex disorder influenced by both environmental and genetic factors. Due to incomplete understanding of its pathophysiology, effective treatment remains challenging. Microribonucleic acids (miRNAs) have emerged as one of the promising epigenetic regulators, with increasing evidence supporting their role in modulating multiple diseases. This insight might inform future research directions toward the development of miRNA-based biomarkers and therapies.
objectiveThis comprehensive scoping review summarizes the current literature on the functions of miRNAs as epigenetic regulators in CRS.
methodsA comprehensive literature review from PubMed database, focusing on chronic rhinosinusitis/nasal polyps and microRNA/miRNA.
resultsNumerous clinical, in vivo, and in vitro studies have identified altered miRNA levels in CRS, and distinct profiles between type 2 and non-type 2 endotypes of CRS. Several studies revealed positive correlations between miRNAs and symptom scores, objective disease measurements, and polyp recurrence. Certain in vivo and in vitro studies also demonstrated the effects of miRNAs changes mainly on inflammation and tissue remodeling, such as epithelial-mesenchymal transition, or fibrin deposition in nasal polyps. The most researched miRNAs in which involved these mechanisms include miR-125b, miR-155, miR-21, and miR-145-5p. miRNAs also have been shown to contribute to other CRS-related processes, including increased mucus secretion and vascular permeability. Collectively, these findings support the effects of miRNA on CRS development. However, a few studies indicated contradictory results, suggesting that miR-21 has a role in anti-inflammation.
conclusionIncreasing evidence highlights the role of miRNAs in CRS pathogenesis. Further research on miRNA-based biomarkers and therapies is warranted.
Indexed as
Identifiers
42086994What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.